Baseline | Location | Control | NE | Control vs. NE group p value |
---|---|---|---|---|
LP ratio | Hemisph | 20 (15–29) | 23 (18–27) | 0.834 |
Lactate (mM/L) | Hemisph | 2.2 (1.4–3.8) | 2.1 (1.7–3.1) | 0.670 |
Pyruvate (mM/L) | Hemisph | 100 (92–134) | 92 (73–108) | 0.643 |
Glucose (mM/L) | Hemisph | 2.5 (1.8–2.8) | 2.6 (2.2–3.2) | 0.183 |
Glutamate (µM/L) | Hemisph | 15 (9–72) | 12 (4–20) | 0.081 |
Glycerol (µM/L) | Hemisph | 93 (58–149) | 62 (45–90) | 0.106 |
Hypoperfusion | Location | Control | NE | Control vs. NE group p value |
---|---|---|---|---|
LP ratio | Hemisph | 66 (38–82) | 24 (19–31) | < 0.001* |
Lactate (mM/L) | Hemisph | 7.8 (6.2–12.3) | 2.5 (2.1–3.6) | < 0.001* |
Pyruvate (mM/L) | Hemisph | 104 (81–177) | 112 (91–132) | 0.670 |
Glucose (mM/L) | Hemisph | 1 (0.4–1.6) | 2.9 (2.4–3.9) | < 0.001* |
Glutamate (µM/L) | Hemisph | 93 (6–155) | 8 (4–11) | 0.001* |
Glycerol (µM/L) | Hemisph | 190 (75–270) | 59 (44–86) | < 0.001* |
Post resuscitation | Location | Control | NE | Control vs. NE group p value |
---|---|---|---|---|
LP ratio | Hemisph | 73 (29–100) | 25 (21–29) | 0.013* |
Lactate (mM/L) | Hemisph | 4.9 (1–6.5) | 1.3 (0.8–1.6) | < 0.001* |
Pyruvate (mM/L) | Hemisph | 102 (71–185) | 108 (100–133) | 0.972 |
Glucose (mM/L) | Hemisph | 0.7 (0.5–0.8) | 2.3 (1.6–2.9) | 0.003* |
Glutamate (µM/L) | Hemisph | 47 (6–110) | 4 (2–7) | 0.005* |
Glycerol (µM/L) | Hemisph | 461 (254–545) | 42 (23–55) | < 0.001* |